Trial Profile
Phase II trial of cannabidivarin in children with severe, drug resistant epilepsy
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 30 Oct 2015
Price :
$35
*
At a glance
- Drugs Cannabidivarin (Primary)
- Indications Epilepsy
- Focus Therapeutic Use
- 30 Oct 2015 New trial record